Article

Daily Medication Pearl: Piperacillin and Tazobactam (Zosyn)

Piperacillin and tazobactam (Zosyn) is indicated for treatment of intra-abdominal infections, skin and skin structure infections, female pelvic infections, community-acquired pneumonia, and nosocomial pneumonia.

Medication Pearl of the Day: Piperacillin and Tazobactam (Zosyn)

Indication: Piperacillin and tazobactam (Zosyn) is a combination penicillin-class antibacterial and β-lactamase inhibitor indicated for treatment of intra-abdominal infections, skin and skin structure infections, female pelvic infections, community-acquired pneumonia, and nosocomial pneumonia.

Insight:

  • Dosing: The usual daily dose of Zosyn for adults is 3.375 g every 6 hours, totaling 13.5 g.
  • Dosage forms: Zosyn for injection 2.25 g, 3.375 g, and 4.5 g lyophilized powder for reconstitution in single-dose vials and 40.5 g lyophilized powder for reconstitution in pharmacy bulk vials.
  • Adverse events: The most common adverse reactions (incidence >5%) are diarrhea, constipation, nausea, headache, and insomnia.
  • Mechanism of action: Piperacillin sodium exerts bactericidal activity by inhibiting septum formation and cell wall synthesis of susceptible bacteria. In vitro, piperacillin is active against a variety of Gram-positive and Gram-negative aerobic and anaerobic bacteria. Tazobactam sodium has little clinically relevant in vitro activity against bacteria due to its reduced affinity to penicillin-binding proteins.

Source: ZOSYN (piperacillin and tazobactam) for injection (fda.gov)

Related Videos
Heart with stethoscope | Image Credit: © DARIKA - stock.adobe.com
Senior Doctor is examining An Asian patient.
Healthcare, pharmacist and woman at counter with medicine or prescription drugs sales at drug store.
Image Credit: © Birdland - stock.adobe.com
pharmacogenetics testing, adverse drug events, personalized medicine, FDA collaboration, USP partnership, health equity, clinical decision support, laboratory challenges, study design, education, precision medicine, stakeholder perspectives, public comment, Texas Medical Center, DNA double helix
Pharmacy, Advocacy, Opioid Awareness Month | Image Credit: pikselstock - stock.adobe.com